Hong Bo

1.1k total citations
43 papers, 836 citations indexed

About

Hong Bo is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hong Bo has authored 43 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 17 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Hong Bo's work include Acute Ischemic Stroke Management (17 papers), Cerebrovascular and Carotid Artery Diseases (16 papers) and MicroRNA in disease regulation (5 papers). Hong Bo is often cited by papers focused on Acute Ischemic Stroke Management (17 papers), Cerebrovascular and Carotid Artery Diseases (16 papers) and MicroRNA in disease regulation (5 papers). Hong Bo collaborates with scholars based in China, United Kingdom and Switzerland. Hong Bo's co-authors include Jianmin Liu, Zifu Li, Qinghai Huang, Wanxin Tang, Pengfei Yang, Jiayang Sun, Tao Zhu, Changyi Li, Jing He and Daoxin Wang and has published in prestigious journals such as PLoS ONE, Stroke and Gene.

In The Last Decade

Hong Bo

42 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Bo China 17 302 213 177 136 115 43 836
Yalan Li China 11 384 1.3× 58 0.3× 367 2.1× 278 2.0× 16 0.1× 25 787
Cheng Liu China 21 536 1.8× 211 1.0× 234 1.3× 242 1.8× 27 0.2× 82 1.5k
Yu-Feng Yan China 12 277 0.9× 110 0.5× 151 0.9× 125 0.9× 59 0.5× 24 731
Yongmei Cao China 15 437 1.4× 125 0.6× 340 1.9× 323 2.4× 42 0.4× 24 927
Sang‐Ah Han South Korea 15 301 1.0× 92 0.4× 112 0.6× 169 1.2× 33 0.3× 49 800
Ching‐Chung Lin Taiwan 16 111 0.4× 79 0.4× 153 0.9× 33 0.2× 12 0.1× 52 636
Xiaoyang Chen China 15 290 1.0× 57 0.3× 80 0.5× 137 1.0× 13 0.1× 63 814
Madhu M. Ouseph United States 13 266 0.9× 90 0.4× 68 0.4× 95 0.7× 39 0.3× 37 719

Countries citing papers authored by Hong Bo

Since Specialization
Citations

This map shows the geographic impact of Hong Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Bo more than expected).

Fields of papers citing papers by Hong Bo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Bo. The network helps show where Hong Bo may publish in the future.

Co-authorship network of co-authors of Hong Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Bo. A scholar is included among the top collaborators of Hong Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Bo. Hong Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Hongyu, Yu Zhou, Zifu Li, et al.. (2022). Single‐Cell RNA‐Sequencing Analyses Revealed Heterogeneity and Dynamic Changes of Metabolic Pathways in Astrocytes at the Acute Phase of Ischemic Stroke. Oxidative Medicine and Cellular Longevity. 2022(1). 1817721–1817721. 16 indexed citations
2.
3.
He, Li, Pei Liu, Xiaoxi Zhang, et al.. (2021). Bibliometric analysis of China’s contribution to the knowledge system of cerebrovascular intervention. Chinese Neurosurgical Journal. 7(1). 3 indexed citations
4.
Hu, Wei, Hongjian Shen, Chunrong Tao, et al.. (2021). Effect of renal impairment on the efficacy and safety of intra-arterial treatment: A post-hoc analysis of DIRECT-MT study. International Journal of Stroke. 17(7). 746–752. 6 indexed citations
5.
Yang, Wenjin, Lei Zhang, Zifu Li, et al.. (2021). Endovascular Treatment for Acute Basilar Artery Occlusion: A Comparison of Arteriosclerotic, Embolic and Tandem Lesions. CardioVascular and Interventional Radiology. 44(12). 1954–1963. 6 indexed citations
6.
Li, He, Peng Liu, Pei Liu, et al.. (2020). Current knowledge of large vascular occlusion due to intracranial atherosclerosis: focusing on early diagnosis. Chinese Neurosurgical Journal. 6(1). 32–32. 11 indexed citations
7.
8.
Li, He, Yin Luo, Yongxin Zhang, et al.. (2019). Glia-derived exosomes: Promising therapeutic targets. Life Sciences. 239. 116951–116951. 20 indexed citations
9.
Zhang, Yongxin, Chang‐Chun Chen, Zhilin Wu, et al.. (2019). Effectiveness of Revive SE in the RAPID registry. Clinical Neuroradiology. 30(3). 495–502. 3 indexed citations
10.
Li, Zifu, Lei Zhang, Dongwei Dai, et al.. (2019). lncRNA NR_120420 promotes SH-SY5Y cells apoptosis by regulating NF-κB after oxygen and glucose deprivation. Gene. 728. 144285–144285. 12 indexed citations
11.
Wu, Qin, Min Fu, Hong Bo, et al.. (2018). Elevated triglycerides level in hospital stay as a risk factor of mortality in patients with severe acute pancreatitis. PLoS ONE. 13(11). e0207875–e0207875. 8 indexed citations
12.
13.
Jiang, Yuanliang, Wenjia Peng, Zhongzhao Teng, et al.. (2016). Local blood pressure associates with the degree of luminal stenosis in patients with atherosclerotic disease in the middle cerebral artery. BioMedical Engineering OnLine. 15(1). 67–67. 3 indexed citations
14.
Li, Zifu, et al.. (2016). Plasma MicroRNA-16 Is a Biomarker for Diagnosis, Stratification, and Prognosis of Hyperacute Cerebral Infarction. PLoS ONE. 11(11). e0166688–e0166688. 43 indexed citations
15.
Tang, Wanxin, Weihua Wu, Hongyu Qiu, Hong Bo, & Songmin Huang. (2013). Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation. Journal of Nephrology. 26(6). 1073–1082. 59 indexed citations
16.
Zhu, Tao, Daoxin Wang, Wei Zhang, et al.. (2013). Andrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB. PLoS ONE. 8(2). e56407–e56407. 189 indexed citations
17.
18.
Xu, Yuanzhi, Kaijun Zhao, Zhi‐gang Yang, et al.. (2012). Decreased plasma decorin levels following acute ischemic stroke: Correlation with MMP-2 and differential expression in TOAST subtypes. Molecular Medicine Reports. 6(6). 1319–1324. 8 indexed citations
19.
Wu, Wei, et al.. (2011). Early protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney. Endocrine. 41(2). 236–247. 34 indexed citations
20.
Liu, Jianmin, et al.. (2004). [Safety and short-term results of stent-assisted angioplasty for the treatment of intracranial arterial stenosis].. PubMed. 42(3). 169–72. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yalan Li Breakdown of academic impact, for papers by Cheng Liu Breakdown of academic impact, for papers by Yu-Feng Yan Breakdown of academic impact, for papers by Yongmei Cao Breakdown of academic impact, for papers by Sang‐Ah Han Breakdown of academic impact, for papers by Ching‐Chung Lin Breakdown of academic impact, for papers by Xiaoyang Chen Breakdown of academic impact, for papers by Madhu M. Ouseph
Rankless by CCL
2026